DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE and CHRONIC KIDNEY DISEASE

13 reports of this reaction

2.5% of all DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE reports

#4 most reported adverse reaction

Overview

CHRONIC KIDNEY DISEASE is the #4 most commonly reported adverse reaction for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, manufactured by RB Health (US) LLC. There are 13 FDA adverse event reports linking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE to CHRONIC KIDNEY DISEASE. This represents approximately 2.5% of all 524 adverse event reports for this drug.

Patients taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CHRONIC KIDNEY DISEASE13 of 524 reports

CHRONIC KIDNEY DISEASE is a less commonly reported adverse event for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

In addition to chronic kidney disease, the following adverse reactions have been reported for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE:

Other Drugs Associated with CHRONIC KIDNEY DISEASE

The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEALUMINUM HYDROXIDE AND MAGNESIUM CARBONATEAMMONIUM LACTATEAMOXICILLINAMPICILLINAMPICILLIN SODIUMASPIRIN AND CAFFEINEATAZANAVIRAVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONEAZITHROMYCINAZITHROMYCIN DIHYDRATEAZITHROMYCIN MONOHYDRATEBARIUM SULFATEBENZOCAINE AND MENTHOLBENZONATATEBICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATEBISMUTH SUBSALICYLATEBUFFERED ASPIRINBUMETANIDECALCITRIOL

Frequently Asked Questions

Does DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE cause CHRONIC KIDNEY DISEASE?

CHRONIC KIDNEY DISEASE has been reported as an adverse event in 13 FDA reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CHRONIC KIDNEY DISEASE with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE?

CHRONIC KIDNEY DISEASE accounts for approximately 2.5% of all adverse event reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience CHRONIC KIDNEY DISEASE while taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE?

If you experience chronic kidney disease while taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE Full ProfileAll Drugs Causing CHRONIC KIDNEY DISEASERB Health (US) LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.